GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anhui Anke Biotechnology (Group) Co Ltd (SZSE:300009) » Definitions » Net-Net Working Capital

Anhui Anke Biotechnology (Group) Co (SZSE:300009) Net-Net Working Capital : ¥0.40 (As of Mar. 2025)


View and export this data going back to 2009. Start your Free Trial

What is Anhui Anke Biotechnology (Group) Co Net-Net Working Capital?

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. This is a conservative way of estimating the company's value.

Anhui Anke Biotechnology (Group) Co's Net-Net Working Capital for the quarter that ended in Mar. 2025 was ¥0.40.

The industry rank for Anhui Anke Biotechnology (Group) Co's Net-Net Working Capital or its related term are showing as below:

SZSE:300009's Price-to-Net-Net-Working-Capital is ranked worse than
88.04% of 878 companies
in the Biotechnology industry
Industry Median: 4.025 vs SZSE:300009: 21.13

Anhui Anke Biotechnology (Group) Co Net-Net Working Capital Historical Data

The historical data trend for Anhui Anke Biotechnology (Group) Co's Net-Net Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Anke Biotechnology (Group) Co Net-Net Working Capital Chart

Anhui Anke Biotechnology (Group) Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net-Net Working Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.36 0.40 0.32 0.46 0.55

Anhui Anke Biotechnology (Group) Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net-Net Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.58 0.38 0.45 0.55 0.40

Competitive Comparison of Anhui Anke Biotechnology (Group) Co's Net-Net Working Capital

For the Biotechnology subindustry, Anhui Anke Biotechnology (Group) Co's Price-to-Net-Net-Working-Capital, along with its competitors' market caps and Price-to-Net-Net-Working-Capital data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Anhui Anke Biotechnology (Group) Co's Price-to-Net-Net-Working-Capital Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anhui Anke Biotechnology (Group) Co's Price-to-Net-Net-Working-Capital distribution charts can be found below:

* The bar in red indicates where Anhui Anke Biotechnology (Group) Co's Price-to-Net-Net-Working-Capital falls into.


;
;

Anhui Anke Biotechnology (Group) Co Net-Net Working Capital Calculation

Anhui Anke Biotechnology (Group) Co's Net-Net Working Capital (NNWC) per share for the fiscal year that ended in Dec. 2024 is calculated as

Net-Net Working Capital(A: Dec. 2024 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1443.879+0.75 * 442.318+0.5 * 297.296-835.412
-0-175.625)/1672.554
=0.55

Anhui Anke Biotechnology (Group) Co's Net-Net Working Capital (NNWC) per share for the quarter that ended in Mar. 2025 is calculated as

Net-Net Working Capital(Q: Mar. 2025 )
=(Cash, Cash Equivalents, Marketable Securities+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(1198.057+0.75 * 464.034+0.5 * 289.142-843.466
-0-175.661)/1672.554
=0.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the Net-Net Working Capital (NNWC), Benjamin Graham assumed that a company's accounts receivable is only worth 75% its value, its inventory is only worth 50% of its value, but its liabilities have to be paid in full.

In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

This is a conservative way of estimating the company's value.


Anhui Anke Biotechnology (Group) Co  (SZSE:300009) Net-Net Working Capital Explanation

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their net-net value. They are collected under our Net-Net screener.


Anhui Anke Biotechnology (Group) Co Net-Net Working Capital Related Terms

Thank you for viewing the detailed overview of Anhui Anke Biotechnology (Group) Co's Net-Net Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Anhui Anke Biotechnology (Group) Co Business Description

Traded in Other Exchanges
N/A
Address
No.9 Changjiang Road, Hefei High-tech Zone, Customs Road 669, Hefei, CHN, 230088
Anhui Anke Biotechnology (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceuticals and health-care products. The Company distributes its product in both domestic and overseas markets. The company operates in more than 30 provinces in China.
Executives
Zhao Hui Directors, executives
Zhou Yuan Yuan Directors, executives
Wang Yong Supervisors
Yao Jian Ping Executives
Wang Rong Hai Directors, executives
Song She Wu Directors, executives
Fu Yong Biao Directors, executives
Jiang Jun Pei Supervisors
Xu Zhen Shan Director
Lu Guang Xin Executives
Yan Xin Wen Executives
Lu Chun Yan Executives
Wu Rui Director
Fan Qing Lin Director
Wang Yong Bin Executives

Anhui Anke Biotechnology (Group) Co Headlines

No Headlines